Clinical Use of Procalcitonin in the Diagnosis of Sepsis: Evaluation of PCT–qSOFA
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Sepsis is a life-threatening medical condition, and the diagnosis of sepsis should be conducted rapidly and accurately. The purpose of this study was to evaluate the diagnostic performance of a combination of procalcitonin (PCT) levels and quick sequential organ failure assessment (qSOFA), namely PCT–qSOFA, for the diagnosis of sepsis. Methods: A total of 204 patients were grouped according to the results of blood culture and systemic inflammatory response syndrome criteria (≥ 2/4) into the bacterial sepsis group (N = 67), the blood culture-negative sepsis group (N = 37), the blood culture-positive group without corresponding clinical symptoms or signs of sepsis (N = 35), and the control group without evidence of sepsis (N = 65). The diagnostic performance of PCT–qSOFA was assessed using the post-test probability analysis. Results: Compared with qSOFA, PCT–qSOFA demonstrated improved post-test probability (from 0.772 to 0.884) and a positive likelihood ratio (from 1.59 to 3.55) when it was applied to all subjects, including those in the intensive care unit (ICU). However, this improvement in diagnostic performance was not observed when PCT–qSOFA was applied to patients outside the ICU. Conclusions: The combined use of PCT and qSOFA can help clinicians identify patients with sepsis, including those in an ICU setting
Abstract
Background: Sepsis is a life-threatening medical condition, and the diagnosis of sepsis should be conducted rapidly and accurately. The purpose of this study was to evaluate the diagnostic performance of a combination of procalcitonin (PCT) levels and quick sequential organ failure assessment (qSOFA), namely PCT–qSOFA, for the diagnosis of sepsis. Methods: A total of 204 patients were grouped according to the results of blood culture and systemic inflammatory response syndrome criteria (≥ 2/4) into the bacterial sepsis group (N = 67), the blood culture-negative sepsis group (N = 37), the blood culture-positive group without corresponding clinical symptoms or signs of sepsis (N = 35), and the control group without evidence of sepsis (N = 65). The diagnostic performance of PCT–qSOFA was assessed using the post-test probability analysis. Results: Compared with qSOFA, PCT–qSOFA demonstrated improved post-test probability (from 0.772 to 0.884) and a positive likelihood ratio (from 1.59 to 3.55) when it was applied to all subjects, including those in the intensive care unit (ICU). However, this improvement in diagnostic performance was not observed when PCT–qSOFA was applied to patients outside the ICU. Conclusions: The combined use of PCT and qSOFA can help clinicians identify patients with sepsis, including those in an ICU setting
참고문헌 (14)
- Singer M, "The third international consensus definitions for sepsis and septic shock(Sepsis-3)", JAMA, 315, pp.801~810 (2016)
- Cortés-Puch I, "Opening the debate on the new sepsis definition change is not necessarily progress: revision of the sepsis definition should be based on new scientific insights", Am J Respir Crit Care Med, 194, pp.16~18 (2016)
- Simpson SQ, "SIRS in the time of Sepsis-3", Chest, 153, pp.34~38 (2018)
- Michael Meisner, "Update on Procalcitonin Measurements", Annals of Laboratory Medicine, 34(4), pp.263~273 (2014), 대한진단검사의학회
- Horan TC, "CDC", NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting, 2008, pp.36, 309~332
- "American College of Chest Physicians", Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, 1992, pp.20, 864~874
- Spoto S, "Procalcitonin and MR-proadrenomedullin combination with SOFA and qSOFA scores for sepsis diagnosis and prognosis : a diagnostic algorithm", Shock, 50, pp.44~52 (2018)
- Kaukonen KM, "Systemic infiammatory response syndrome criteria in defining severe sepsis", N Engl J Med, 372, pp.1629~1638 (2015)
- Dellinger RP, "Surviving sepsis campaign : international guidelines for management of severe sepsis and septic shock : 2012", Crit Care Med, 41, pp.580~637 (2013)
- Salomão R, "Sepsis: evolving concepts and challenges", Braz J Med Biol Res, 52, pp.e8595~ (2019)
- Vincent JL, "qSOFA does not replace SIRS in the definition of sepsis", Crit Care, 20, pp.210~ (2016)
- Faix JD, "Biomarkers of sepsis", Crit Rev Clin Lab Sci, 50, pp.23~36 (2013)
- Singh M, "Bedside procalcitonin and acute care", Int J Crit Illn Inj Sci, 4, pp.233~237 (2014)
- Cortés-Puch I, "Opening the debate on the new sepsis definition change is not necessarily progress : revision of the sepsis definition should be based on new scientific insights", Am J Respir Crit Care Med, 194, pp.16~18 (2016)